Clinical Trial Update: Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for topical remetinostat in treating cutaneous basal cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Basal Cell Carcinoma

Drugs mentioned

• remetinostat (remetinostat)

Snippet

Sponsor: Kavita Sarin | Conditions: Skin Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-05